H-CYTE, Inc. (OTCPK:HCYT) entered into a letter of intent to acquire Catheter Precision, Inc. on January 11, 2022. The transaction is subject to a definitive agreement and customary closing conditions. The transaction is expected to close in the first quarter of 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.02 USD | -33.33% | -.--% | -82.76% |
1st Jan change | Capi. | |
---|---|---|
-82.76% | 107K | |
+7.93% | 219B | |
+7.53% | 183B | |
+15.20% | 136B | |
+27.02% | 107B | |
-1.14% | 63.07B | |
+7.23% | 52.55B | |
+12.58% | 51.28B | |
+1.61% | 41.21B | |
+5.32% | 36.43B |
- Stock Market
- Equities
- IVRN Stock
- News Innoveren Scientific Inc.
- H-CYTE, Inc. entered into a letter of intent to acquire Catheter Precision, Inc.